Covid vaccine developer CureVac shores up C-suite as it heads toward IPO

The local drugmaker has firmed up its executive team, hiring a Novartis executive and finalizing its CEO pick in advance of its must-anticipated IPO.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.